Publications
Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach.
– ACS Infectious Diseases
(2022)
8,
296
(doi: 10.1021/acsinfecdis.1c00432)
A new strategy for hit generation: Novel in cellulo active inhibitors of CYP121A1 from Mycobacterium tuberculosis via a combined X-ray crystallographic and phenotypic screening approach (XP screen).
– European Journal of Medicinal Chemistry
(2022)
230,
114105
(doi: 10.1016/j.ejmech.2022.114105)
10.02 Bicyclic 5-5 Systems: Three Heteroatoms 1:2
(2022)
41
A fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis
– Comput Struct Biotechnol J
(2021)
19,
3491
(doi: 10.1016/j.csbj.2021.06.006)
Targeting Mycobacterium tuberculosis CoaBC through Chemical Inhibition of 4′-Phosphopantothenoyl- l -cysteine Synthetase (CoaB) Activity
– ACS infectious diseases
(2021)
7,
1666
(doi: 10.1021/acsinfecdis.0c00904)
A Fragment-based approach to assess the ligandability of ArgB, ArgC, ArgD and ArgF in the L-arginine biosynthetic pathway of Mycobacterium tuberculosis
(2021)
(doi: 10.1101/2021.03.12.435067)
A small-molecule inhibitor of the BRCA2-RAD51 interaction modulates RAD51 assembly and potentiates DNA damage-induced cell death
– Cell chemical biology
(2021)
28,
835
Inhibiting Mycobacterium tuberculosis CoaBC by targeting an allosteric site.
– Nature Communications
(2021)
12,
143
(doi: 10.1038/s41467-020-20224-x)
- <
- 2 of 9